Human Microbiome Therapeutic

Human Microbiome Therapeutics Market Set to Exceed $1,544.6 Million By 2027 | CAGR 23.8%

Forecast to 2020

Human Microbiome Therapeutics Market Size Worth $1,544.6 Million By 2027

“Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, and Prescription Drugs); By Therapeutic Area (Autoimmune Disorders, Dental Disorders, Digestive and Gastrointestinal Disorders, Dermatological Disorders, Infectious Disease, Metabolic Disorders, Oncology, and Others);

By Indication; By Approach; By Regions; Segment Forecast, 2020 –2027” The global human microbiome therapeutics market size is expected to reach USD 1,544.6 million by 2027 according to a new study by Polaris Market Research.

Microbiome refers to the residing micro-organisms genomes in the human body, particularly in the gut. The human body comprises more than 100 trillion microbes and around 2 million microbe genomes. These microbiota plays a significant role in the body’s physiological functions and includes viruses, bacteria, and fungi. Primarily it has Bacteroidetes (gram negative) and Firmicutes, commonly Clostridium and Lactobacillus sp. (gram positive). The majority of these are strict anaerobes, with fungi and archaebacteria comprising less than 1 per cent of the total population.

Browse Detailed Research Report On Human Microbiome Therapeutics Market Analysis: https://www.polarismarketresearch.com/industry-analysis/human-microbiome-therapeuticsmarket The global market is driven by an increased focus on microbiome based early diagnosis of diseases, increase in the prevalence of diseases due to dysbiosis, rising collaborations, and strongly funded government backed microbiome research projects. In November 2019, the Million Microbiome of Humans Project (MMHP) was launched in collaboration with France, Denmark, China, Latvia, Sweden and other countries to co-operate in meta-genomic research. The aim is to create the largest human microbiome database from analyzing more than one million samples gathered from reproductive tract, gut, skin, and other organs in the next few years.

Market participants such as Enterome Bioscience, Biotagenics, Seres Therapeutics, Oxidien Pharmaceuticals, LLC, BoobyBiome, 4D Pharma PLC, UBiome, Carbiotix, E.I. du Pont de Nemours and Company, Finch Therapeutics, GNUbiotics Sciences, ClearB Therapeutics, GoodBelly, GoodGut, Synlogic, Second Genome, 16S Technologies, 5QBD-Biotech, Vedanta Biosciences, Holobiome, Commense, Ferring Pharmaceuticals, Evelo Biosciences, CoreBiome, Igen Biolab Group, ViThera Pharmaceuticals, DermBiont, Hyggut, Embion Technologies, Lactobio, BiomX, Exeliom Biosciences, and LNC Therapeutics are some of the key players operating in the concerned market.

Request

for

sample:

https://www.polarismarketresearch.com/industry-analysis/human-

microbiome-therapeutics-market/request-for-sample -2-

Human Microbiome Therapeutics Market Size Worth $1,544.6 Million By 2027

Recently, in July 2020, 4D pharma plc., the UK based pharma company engaged in the development of live bio-therapeutics announced that patient enrollment for its phase II trial of its candidate oral immune-modulator MRx-4DP0004 for patients hospitalized with COVID-19 is open, and dosing to start very soon. The company is world leader in the production of live bio-therapeutics (live microbiome used to cure disease). Its products are the orally delivered single strain bacteria, which are naturally present in the human gut.

TABLE OF CONTENTS 1. Introduction 1.1. Report Description 1.1.1. Objectives of the Study 1.1.2. Market Scope 1.1.3. Assumptions 1.2. Stakeholders 2. Executive Summary 2.1. Market Highlights 3. Research Methodology 3.1. Overview 3.1.1. Data Mining 3.2. Data Sources 3.2.1. Primary Sources 3.2.2. Secondary Sources 4. Human Microbiome Therapeutics Market Insights 4.1. Human Microbiome Therapeutics – Industry snapshot 4.2. Human Microbiome Therapeutics Market Dynamics 4.2.1. Drivers and Opportunities 4.2.1.1. Surge in the infectious diseases -3-

Human Microbiome Therapeutics Market Size Worth $1,544.6 Million By 2027

4.2.1.2. Government backed funding 4.2.2. Restraints and Challenges 4.2.2.1. Side effects associated with the usage of biotherapeutics 4.3. Porter’s Five Forces Analysis 4.3.1. Bargaining Power of Suppliers (Moderate) 4.3.2. Threats of New Entrants: (Low) 4.3.3. Bargaining Power of Buyers (Moderate) 4.3.4. Threat of Substitute (Moderate) 4.3.5. Rivalry among existing firms (High) 4.4. PESTLE Analysis 4.5. Human Microbiome Therapeutics Market Industry trends 5. Human Microbiome Therapeutics Market Assessment by Product 5.1. Key Findings 5.2. Introduction 5.2.1. Global Human Microbiome Therapeutics Market, By Product, 2015 – 2026 (USD Million) 5.3. Probiotics 5.3.1. Global Human Microbiome Therapeutics Market, by Probiotics, by Region, 20162027 (USD Million) 5.4. Prebiotics 5.4.1. Global Human Microbiome Therapeutics Market, by Prebiotics, by Region, 20162027 (USD Million) 5.5. Medical Foods 5.5.1. Global Human Microbiome Therapeutics Market, by Medical Foods, by Region, 2016- 2027 (USD Million) 5.6. Prescription Drugs 5.6.1. Global Human Microbiome Therapeutics Market, by Prescription Drugs, by Region, 2016- 2027 (USD Million) 6. Global Human Microbiome Therapeutics Market, by Therapeutic Area 6.1. Key Findings 6.2. Introduction 6.2.1. Global Human Microbiome Therapeutics Market, By Therapeutic Area, 2015 – 2026 (USD Million) 6.3. Autoimmune Disorders 6.3.1. Global Human Microbiome Therapeutics Market, by Autoimmune Disorders, By Region, 2016- 2027 (USD Million) 6.4. Dental Disorders 6.4.1. Global Human Microbiome Therapeutics Market, by Dental Disorders, by Region, 2016- 2027 (USD Million) 6.5. Digestive and Gastrointestinal Disorders 6.5.1. Global Human Microbiome Therapeutics Market, by Digestive and Gastrointestinal Disorders, by Region, 2016- 2027 (USD Million) 6.6. Dermatological Disorders 6.6.1. Global Human Microbiome Therapeutics Market, by Dermatological Disorders, by Region, 2016- 2027 (USD Million) 6.7. Infectious Disease 6.7.1. Global Human Microbiome Therapeutics Market, by Infectious Disease, by Region, 2016- 2027 (USD Million) 6.8. Metabolic Disorders 6.8.1. Global Human Microbiome Therapeutics Market, by Metabolic Disorders, by Region, 2016- 2027 (USD Million) 6.9. Oncology -4-

Human Microbiome Therapeutics Market Size Worth $1,544.6 Million By 2027

6.9.1. Global Human Microbiome Therapeutics Market, by Oncology, by Region, 20162027 (USD Million) 6.10.

Others 6.10.1. Global Human Microbiome Therapeutics Market, by Others, by Region, 20162027 (USD Million) 7. Global Human Microbiome Therapeutics Market, by Indication 7.1. Key Findings 7.2. Introduction 7.2.1. Global Human Microbiome Therapeutics Market, By Indication, 2015 – 2026 (USD Million) 7.3. Acne Vulgaris 7.3.1. Global Human Microbiome Therapeutics Market, by Acne Vulgaris, By Region, 2016- 2027 (USD Million) 7.4. Atopic Dermatitis 7.4.1. Global Human Microbiome Therapeutics Market, by Atopic Dermatitis, by Region, 2016- 2027 (USD Million) 7.5. Clostridium difficile Infection 7.5.1. Global Human Microbiome Therapeutics Market, by Clostridium difficile Infection,

by Region, 2016- 2027 (USD Million) 7.6. Colorectal Cancer 7.6.1. Global Human Microbiome Therapeutics Market, by Colorectal Cancer, by Region, 2016- 2027 (USD Million) 7.7. Diabetes 7.7.1. Global Human Microbiome Therapeutics Market, by Diabetes, by Region, 20162027 (USD Million) 7.8. Inflammatory Bowel Disease (IBD) 7.8.1. Global Human Microbiome Therapeutics Market, by Inflammatory Bowel Disease (IBD), by Region, 2016- 2027 (USD Million) 7.9. Lactose Intolerance 7.9.1. Global Human Microbiome Therapeutics Market, by Lactose Intolerance, by Region, 2016- 2027 (USD Million) 7.10.

Lung Cancer 7.10.1. Global Human Microbiome Therapeutics Market, by Lung Cancer, by Region, 2016- 2027 (USD Million) 7.11.

Non-alcoholic steatohepatitis (NASH) 7.11.1. Global Human Microbiome Therapeutics Market, by Non-alcoholic steatohepatitis (NASH), by Region, 2016- 2027 (USD Million) 7.12.

Obesity 7.12.1. Global Human Microbiome Therapeutics Market, by Obesity, by Region, 20162027 (USD Million) 7.13.

Coeliac Disease 7.13.1. Global Human Microbiome Therapeutics Market, by Coeliac Disease, by Region, 2016- 2027 (USD Million) 8. Human Microbiome Therapeutics Market Assessment by Approach 8.1. Key Findings 8.2. Introduction 8.2.1. Global Human Microbiome Therapeutics Market, By Approach, 2015 – 2026 (USD Million) 8.3. Small Molecule Therapies 8.3.1. Global Human Microbiome Therapeutics Market, by Small Molecule Therapies,

by Region, 2016- 2027 (USD Million) 8.4. Single Strain Whole Bacteria -5-

Human Microbiome Therapeutics Market Size Worth $1,544.6 Million By 2027

8.4.1. Global Human Microbiome Therapeutics Market, by Single Strain Whole Bacteria, by Region, 2016- 2027 (USD Million) 8.5. Microbial Consortia 8.5.1. Global Human Microbiome Therapeutics Market, by Microbial Consortia, by Region, 2016- 2027 (USD Million) 8.6. Genetically Modified Single Strain Bacteria 8.6.1. Global Human Microbiome Therapeutics Market, by Genetically Modified Single Strain Bacteria, by Region, 2016- 2027 (USD Million) 8.7. Phage Cocktail 8.7.1. Global Human Microbiome Therapeutics Market, by Phage Cocktail, by Region, 2016- 2027 (USD Million) 8.8. Microbial Ecosystems 8.8.1. Global Human Microbiome Therapeutics Market, by Microbial Ecosystems, by Region, 2016- 2027 (USD Million) 9. Human Microbiome Therapeutics Market Assessment by Geography 9.1. Key findings 9.2. Introduction 9.2.1. Human Microbiome Therapeutics Market Assessment, By Geography, 20162027 (USD Million) 9.3. Human Microbiome Therapeutics Market – North America 9.3.1. North America: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.3.2. North America: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.3.3. North America: Human Microbiome Therapeutics Market, By Indication, 2016 2027 (USD Million) 9.3.4. North America: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 9.3.5. Human Microbiome Therapeutics Market – U.S. 9.3.5.1. U.S.: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.3.5.2. U.S.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.3.5.3. U.S.: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million) 9.3.5.4. U.S.: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million) 9.3.6. Human Microbiome Therapeutics Market – Canada 9.3.6.1. Canada: Human Microbiome Therapeutics Market, By Product, 20162027 (USD Million) 9.3.6.2. Canada.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.3.6.3. Canada: Human Microbiome Therapeutics Market, By Indication, 20162027 (USD Million) 9.3.6.4. Canada: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 9.4. Human Microbiome Therapeutics Market – Europe 9.4.1. Europe: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.4.2. Europe.: Human Microbiome Therapeutics Market, By Therapeutic Area, 20162027 (USD Million)

-6-

Human Microbiome Therapeutics Market Size Worth $1,544.6 Million By 2027

9.4.3. Europe: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million) 9.4.4. Europe: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million) 9.4.5. Human Microbiome Therapeutics Market – UK 9.4.5.1. UK: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.4.5.2. UK.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.4.5.3. UK: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million) 9.4.5.4. UK: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million) 9.4.6. Human Microbiome Therapeutics Market – France 9.4.6.1. France: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.4.6.2. France.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.4.6.3. France: Human Microbiome Therapeutics Market, By Indication, 20162027 (USD Million) 9.4.6.4. France: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 9.4.7. Human Microbiome Therapeutics Market – Germany 9.4.7.1. Germany: Human Microbiome Therapeutics Market, By Product, 20162027 (USD Million) 9.4.7.2. Germany.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.4.7.3. Germany: Human Microbiome Therapeutics Market, By Indication, 20162027 (USD Million) 9.4.7.4. Germany: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 9.4.8. Human Microbiome Therapeutics Market – Italy 9.4.8.1. Italy: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.4.8.2. Italy.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.4.8.3. Italy: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million) 9.4.8.4. Italy: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million) 9.4.9. 7.9.5 Human Microbiome Therapeutics Market – Netherlands 9.4.9.1. Netherlands: Human Microbiome Therapeutics Market, By Product, 20162027 (USD Million) 9.4.9.2. Netherlands.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.4.9.3. Netherlands: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million) 9.4.9.4. Netherlands: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million) 9.4.10. Human Microbiome Therapeutics Market – Spain 9.4.10.1. Spain: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) -7-

Human Microbiome Therapeutics Market Size Worth $1,544.6 Million By 2027

9.4.10.2. Spain.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.4.10.3. Spain: Human Microbiome Therapeutics Market, By Indication, 20162027 (USD Million) 9.4.10.4. Spain: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 9.4.11. Human Microbiome Therapeutics Market – Austria 9.4.11.1. Austria: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.4.11.2. Austria.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.4.11.3. Austria: Human Microbiome Therapeutics Market, By Indication, 20162027 (USD Million) 9.4.11.4. Austria: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 9.5. Human Microbiome Therapeutics Market – Asia-Pacific 9.5.1. Asia Pacific: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.5.2. Asia Pacific.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.5.3. Asia-pacific: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million) 9.5.4. Asia-pacific: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million) 9.5.5. Human Microbiome Therapeutics Market – China 9.5.5.1. China: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.5.5.2. China.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.5.5.3. China: Human Microbiome Therapeutics Market, By Indication, 20162027 (USD Million) 9.5.5.4. China: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 9.5.6. Human Microbiome Therapeutics Market – India 9.5.6.1. India: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.5.6.2. India.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.5.6.3. India: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million) 9.5.6.4. India: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million) 9.5.7. Human Microbiome Therapeutics Market – Malaysia 9.5.7.1. Malaysia: Human Microbiome Therapeutics Market, By Product, 20162027 (USD Million) 9.5.7.2. Malaysia.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.5.7.3. Malaysia: Human Microbiome Therapeutics Market, By Indication, 20162027 (USD Million) 9.5.7.4. Malaysia: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 9.5.8. Human Microbiome Therapeutics Market – Japan -8-

Human Microbiome Therapeutics Market Size Worth $1,544.6 Million By 2027

9.5.8.1. Japan: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.5.8.2. Japan: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.5.8.3. Japan: Human Microbiome Therapeutics Market, By Indication, 20162027 (USD Million) 9.5.8.4. Japan: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 9.5.9. Human Microbiome Therapeutics Market – South Korea 9.5.9.1. South Korea: Human Microbiome Therapeutics Market, By Product, 20162027 (USD Million) 9.5.9.2. South Korea.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.5.9.3. South Korea: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million) 9.5.9.4. South Korea: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million) 9.5.10. Human Microbiome Therapeutics Market – Australia 9.5.10.1. Australia: Human Microbiome Therapeutics Market, By Product, 20162027 (USD Million) 9.5.10.2. Australia.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.5.10.3. Australia: Human Microbiome Therapeutics Market, By Indication, 20162027 (USD Million) 9.5.10.4. Australia: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 9.6. Human Microbiome Therapeutics Market – Middle East & Africa 9.6.1. Middle East & Africa: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.6.2. Middle East & Africa.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.6.3. Middle East & Africa: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million) 9.6.4. Middle East & Africa: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million) 9.6.5. Human Microbiome Therapeutics Market – Saudi Arabia 9.6.5.1. Saudi Arabia: Human Microbiome Therapeutics Market, By Product, 20162027 (USD Million) 9.6.5.2. Saudi Arabia.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.6.5.3. Saudi Arabia: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million) 9.6.5.4. Saudi Arabia: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million) 9.6.6. Human Microbiome Therapeutics Market – UAE 9.6.6.1. UAE: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.6.6.2. UAE.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.6.6.3. UAE: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million)

-9-

Human Microbiome Therapeutics Market Size Worth $1,544.6 Million By 2027

9.6.6.4. UAE: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million) 9.6.7. Human Microbiome Therapeutics Market – Israel 9.6.7.1. Israel: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.6.7.2. Israel.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.6.7.3. Israel: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million) 9.6.7.4. Israel: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million) 9.6.8. Human Microbiome Therapeutics Market – South Africa 9.6.8.1. South Africa: Human Microbiome Therapeutics Market, By Product, 20162027 (USD Million) 9.6.8.2. South Africa.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.6.8.3. South Africa: Human Microbiome Therapeutics Market, By Indication, 2016- 2027 (USD Million) 9.6.8.4. South Africa: Human Microbiome Therapeutics Market, By Approach, 2016- 2027 (USD Million) 9.7. Human Microbiome Therapeutics Market – Latin America 9.7.1. Latin America: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.7.2. Latin America.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.7.3. Latin America: Human Microbiome Therapeutics Market, By Indication, 20162027 (USD Million) 9.7.4. Latin America: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 9.7.5. Human Microbiome Therapeutics Market – Mexico 9.7.5.1. Mexico: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.7.5.2. Mexico: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.7.5.3. Mexico: Human Microbiome Therapeutics Market, By Indication, 20162027 (USD Million) 9.7.5.4. Mexico: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 9.7.6. Human Microbiome Therapeutics Market – Brazil 9.7.6.1. Brazil: Human Microbiome Therapeutics Market, By Product, 2016- 2027 (USD Million) 9.7.6.2. Brazil.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) 9.7.6.3. Brazil: Human Microbiome Therapeutics Market, By Indication, 20162027 (USD Million) 9.7.6.4. Brazil: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 9.7.7. Human Microbiome Therapeutics Market – Argentina 9.7.7.1. Argentina: Human Microbiome Therapeutics Market, By Product, 20162027 (USD Million) 9.7.7.2. Argentina.: Human Microbiome Therapeutics Market, By Therapeutic Area, 2016- 2027 (USD Million) - 10 -

Human Microbiome Therapeutics Market Size Worth $1,544.6 Million By 2027

9.7.7.3. Argentina: Human Microbiome Therapeutics Market, By Indication, 20162027 (USD Million) 9.7.7.4. Argentina: Human Microbiome Therapeutics Market, By Approach, 20162027 (USD Million) 10. Competitive Landscape 10.1.

Expansion and Acquisition Analysis 10.1.1. Expansion Analysis 10.1.2. Acquisition Analysis 10.2.

Partnerships/Collaborations/Agreements/Exhibitions 11. Company Profiles 11.1.

Enterome Bioscience 11.1.1. Company Overview 11.1.2. Financial Performance 11.1.3. Product Benchmarking 11.1.4. Recent Development 11.2.

Seres Therapeutics 11.2.1. Company Overview 11.2.2. Financial Performance 11.2.3. Product Benchmarking 11.2.4. Recent Development 11.3.

4D Pharma PLC 11.3.1. Company Overview 11.3.2. Financial Performance 11.3.3. Product Benchmarking 11.3.4. Recent Development 11.4.

Finch Therapeutics 11.4.1. Company Overview 11.4.2. Financial Performance 11.4.3. Product Benchmarking 11.4.4. Recent Development 11.5.

GNUbiotics Sciences 11.5.1. Company Overview 11.5.2. Financial Performance 11.5.3. Product Benchmarking 11.5.4. Recent Development 11.6.

5QBD-Biotech 11.6.1. Company Overview 11.6.2. Financial Performance 11.6.3. Product Benchmarking 11.6.4. Recent Development 11.7.

Vedanta Biosciences 11.7.1. Company Overview 11.7.2. Financial Performance 11.7.3. Product Benchmarking 11.7.4. Recent Development 11.8.

Ferring Pharmaceuticals 11.8.1. Company Overview 11.8.2. Financial Performance 11.8.3. Product Benchmarking 11.8.4. Recent Development 11.9.

Evelo Biosciences 11.9.1. Company Overview - 11 -

Human Microbiome Therapeutics Market Size Worth $1,544.6 Million By 2027

11.9.2. Financial Performance 11.9.3. Product Benchmarking 11.9.4. Recent Development 11.10.

Igen Biolab Group 11.10.1.

Company Overview 11.10.2.

Financial Performance 11.10.3.

Product Benchmarking 11.10.4.

Recent Development 11.11.

Embion Technologies 11.11.1.

Company Overview 11.11.2.

Financial Performance 11.11.3.

Product Benchmarking 11.11.4.

Recent Development

Access Press Release on Human Microbiome Therapeutics Market: https://www.polarismarketresearch.com/press-releases/human-microbiome-therapeuticsmarket

About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com/

- 12 -